A groundbreaking study conducted in Kerala has revealed that generic medicines are not only as effective as their branded counterparts but also cost up to 50% less. This finding holds significant implications for Kerala, where medicines—especially those for chronic conditions—account for the largest out-of-pocket health expenditure, constituting nearly two-thirds of all household healthcare spending. By switching to generic alternatives, patients requiring daily, lifelong medication could save a minimum of Rs 10,000 to Rs 15,000 annually, thereby reducing the need to ration or skip essential drugs.
Study Methodology and Findings
The research was carried out by the Mission for Ethics and Science in Healthcare (MESH) between August 2025 and December 2025. It was a first-of-its-kind, citizen-funded study in Kerala, with findings published in the international journal Frontiers in Pharmacology on Wednesday. Researchers tested 131 samples of 22 essential medicines (tablets or capsules) obtained from licensed retail outlets across Kerala, including Central government Jan Aushadhi outlets, Kerala Medical Services Corporation Ltd (KMSCL) distribution counters, private generic chains, and leading branded pharmacies.
All samples passed every quality test—drug content, dissolution, purity, and uniformity—regardless of price or brand. Notably, Jan Aushadhi stores were found to be the most affordable among all sources.
Expert Insights
Dr. Cyriac Abby Philips, the lead researcher widely known as LiverDoc on social media, stated: “There is a persistent belief—shared by patients and doctors alike—that cheaper generic medicines are somehow inferior to expensive branded ones. But now there is firm evidence for doctors to prescribe generics with confidence and for patients, it is real money saved with no compromise on safety.”
However, the researchers cautioned against overgeneralization. Dr. Abby added: “Our findings are bounded by real limitations. The study was confined to Kerala, which has strong healthcare infrastructure; samples came from legitimate retail outlets, not unregulated or informal markets; and we tested at a single point in time. Therefore, where you buy from matters as much as what you buy.”
Broader Context and Concerns
The World Health Organization estimates that roughly one in ten medicines in low- and middle-income countries are substandard or falsified. Pharmacologist Dr. T G Ravikumar highlighted a paradox: “There are inherent quality issues with both branded and generic medicines sold in India. Otherwise, how does one explain the irony that despite being the world’s largest provider of generic medicines, we have separate manufacturing units for drugs exported abroad and drugs sold in domestic markets? While one complies with US and European standards, the other has no such strict quality adherences, thereby affecting the quality of both generic and branded drugs sold here.”
This study provides crucial evidence to support the use of generics, but experts emphasize the need for continued vigilance and regulatory oversight to ensure consistent quality across all sources.
